1. Division of Hematology, Department of Internal Medicine, The Ohio State University James Cancer Hospital, Columbus, OH;
2. Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY;
3. Section of Hematology/Oncology, University of Manitoba, Winnipeg, MB, Canada;
4. Department of Medicine, Hofstra North Shore-Long Island Jewish School of Medicine, Hofstra University, Hempstead, NY;
5. Division of Hematology, Mayo Clinic, Rochester, MN;
6. Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom;
7. Department of Haemato-Oncology, Royal Marsden Biomedical Research Centre, London, United Kingdom;
8. First Department of Internal Medicine, Semmelweis University, Budapest, Hungary;
9. Haematology Department, University Hospital Trust and Cancer Sciences Unit, Cancer Research UK and National Institute for Health Research Experimental Cancer Medicine Centres, Faculty of Medicine, University of Southampton, Southampton, United Kingdom;
10. Hematology, Azienda Ospedaliera Universitaria Senese, Siena, Italy;
11. Department of Medicine V, University of Heidelberg, Heidelberg, Germany;
12. Department of Hematology, Skåne University Hospital and Stem Cell Center, Lund University, Lund, Sweden;
13. Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD;
14. Department of Medicine, University of Alberta, Edmonton, AB, Canada;
15. Department of Pathology, The Ohio State University, Columbus, OH;
16. Department of Hematology, Hospital Clinic, University of Barcelona, Barcelona, Spain;
17. Department of Hematology, Hadassah University Hospital and Hebrew University Medical School, Jerusalem, Israel;
18. Department of Laboratory Medicine and Pathology, University Health Network, Toronto, ON, Canada;
19. Section of Developmental Therapeutics, Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX;
20. Department of Hematology, Medical University of Lodz, Lodz, Poland;
21. Division of Hematology and Oncology, Scripps Clinic, La Jolla, CA;
22. Haematology Department, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia;
23. Hematology Unit, Bnai-Zion Medical Center, and the Rappaport Faculty of Medicine, Technion Institute of Technology, Haifa, Israel;
24. Institute of Hematology, Department of Medicine, University and Hospital of Perugia, Perugia, Italy;
25. Department of Hematology, Centre Hospitalier Universitaire Côte de Nacre, Caen, France;
26. James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY;
27. Department of Molecular Therapy in Hematology and Oncology, National Center for Tumor Diseases and German Cancer Research Center (DKFZ), Heidelberg, Germany; and
28. Institute of Hematology “Seràgnoli,” University of Bologna, Bologna, Italy